Reply to J.-G. Wang et al.

Leavey, Patrick J; Krailo, Mark D; DuBois, Steven G; Reed, Damon R; Janeway, Katherine A; Mascarenhas, Leo

Leavey, Patrick J; Krailo, Mark D; DuBois, Steven G; Reed, Damon R; Janeway, Katherine A; Mascarenhas, Leo.

Afiliação

Leavey PJ; Patrick J. Leavey, MD, UT Southwestern Medical Center Dallas and Children's Health, Children's Medical, Center Dallas, Dallas, TX; Mark D. Krailo, PhD, University of Southern California, Los Angeles, CA; Steven G. DuBois, MD, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard M
Krailo MD; Patrick J. Leavey, MD, UT Southwestern Medical Center Dallas and Children's Health, Children's Medical, Center Dallas, Dallas, TX; Mark D. Krailo, PhD, University of Southern California, Los Angeles, CA; Steven G. DuBois, MD, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard M
DuBois SG; Patrick J. Leavey, MD, UT Southwestern Medical Center Dallas and Children's Health, Children's Medical, Center Dallas, Dallas, TX; Mark D. Krailo, PhD, University of Southern California, Los Angeles, CA; Steven G. DuBois, MD, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard M
Reed DR; Patrick J. Leavey, MD, UT Southwestern Medical Center Dallas and Children's Health, Children's Medical, Center Dallas, Dallas, TX; Mark D. Krailo, PhD, University of Southern California, Los Angeles, CA; Steven G. DuBois, MD, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard M
Janeway KA; Patrick J. Leavey, MD, UT Southwestern Medical Center Dallas and Children's Health, Children's Medical, Center Dallas, Dallas, TX; Mark D. Krailo, PhD, University of Southern California, Los Angeles, CA; Steven G. DuBois, MD, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard M
Mascarenhas L; Patrick J. Leavey, MD, UT Southwestern Medical Center Dallas and Children's Health, Children's Medical, Center Dallas, Dallas, TX; Mark D. Krailo, PhD, University of Southern California, Los Angeles, CA; Steven G. DuBois, MD, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard M

J Clin Oncol ; 40(13): 1507-1508, 2022 05 01.

Article em En | MEDLINE | ID: mdl-35235382

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Clin Oncol Ano de publicação: 2022 Tipo de documento: Article